News | March 08, 2022
Moderna to set up first mRNA facility in Kenya
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care
OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation
Company has bought 7.73 million shares for KRW 146.1 billion thus securing the largest shareholder status in Bukwang Pharmaceutical
In this role, Jeffrey DeAlmeida takes responsibility for BASF’s global pharmaceutical solutions portfolio and the Nutrition & Health business in North and South America
Alchemee's flagship brand Proactiv@ is an iconic product synonymous with acne care
The transaction as well as the open offer is expected to be completed by June this year.
The companies plan to use the proceeds to retire debt and expand operations
Equity investment follows recent EUR 520 m licensing agreement providing Grand Pharma (GP) access to three of ITM’s targeted radionuclide therapeutic and diagnostic candidates for Greater China
Funding will support continued advancement of Centauri’s antimicrobial resistance research to identify novel therapeutic candidates using its proprietary Alphamer platform
Subscribe To Our Newsletter & Stay Updated
